Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

J&J publish promising Ebola vaccine data

September 14, 2021 Research and Development

Johnson & Johnson have released promising data regarding their Ebola vaccine regimen, as it demonstrates antibody immune responses in adults …
News
valneva-05

Valneva COVID-19 vaccine deal pulled by UK government

September 13, 2021 Research and Development, Sales and Marketing Boris Johnson, Scotland, UK government, Vaccine, Valneva, booster, covid19

Boris Johnson and the UK government have terminated its deal with specialist vaccine company Valneva after it was alleged the …
News
nhs_old_hospital_1

NHS lung cancer patients to receive Amgen’s tumour-stopping drug

September 10, 2021 Medical Communications, Research and Development

NHS patients will be the first in Europe to receive a new drug that can prevent lung cancer tumour growth, …
News

FDA grants Fast Track Designation for Vor Biopharma’s AML drug

September 10, 2021 Medical Communications, Research and Development

Vor Biopharma has announced that the FDA has granted their acute myeloid leukemia (AML) engineered hematopoietic stem cell therapy (eHSC), …
News

Trials of former Theranos CEO Elizabeth Holmes are underway

September 8, 2021 Medical Communications, Research and Development

The highly anticipated trials of Elizabeth Holmes, founder and former CEO of the now-defunct Theranos, have commenced. Prosecutors are to …
News

J&J’s prostate cancer drug recommended by NICE

September 8, 2021 Research and Development

J&J have announced NICE are recommending apalutamide for treating prostate cancer following new draft guidance by the body. This is …
News
clinical_trials_2

Amneal’s IPX-203 shows promising results for motor fluctuations in Parkinson’s disease

September 8, 2021 Research and Development

Amneal Pharmaceuticals has recently announced that its product IPX-203 (carbidopa + levodopa, (CD/LD)) achieved key primary and secondary endpoints in …
News
cdc-un8tv9pw2ik-unsplash_1

COVID booster vaccines to get green light in “next few days”, according to health secretary

September 8, 2021 Research and Development

Coronavirus booster jabs are expected to be approved in “the next few days”, the UK Health Secretary, Sajid David, has …
News

STI rates remain at concerning level despite 2020 fall

September 8, 2021 Research and Development

New data from Public Health England (PHE) reveal that despite diagnoses of sexually transmitted infections (STIs) decreasing in 2020 by …
News
sanofi_hq__boetie_hall_web

Sanofi acquires Kadmon in $1.9 billion deal

September 8, 2021 Research and Development

Sanofi has announced that is has entered into a definitive merger agreement with Kadmon Holdings adding Rezurock (belumosudil) to its …
News

FDA halts BioMarin’s PKU gene therapy trial

September 7, 2021 Manufacturing and Production, Medical Communications, Research and Development

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …
News

Vaginal ring could help prevent HIV infection in women

September 7, 2021 Manufacturing and Production, Research and Development

Researchers from the Kenya Medical Research Institute (KEMRI) are exploring the use of an intra vaginal ring containing anti-HIV medication …
News

Sinovac booster jab reverses antibody drop from Delta variant, study finds

September 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …
News
astrazeneca_sign_sky

AstraZeneca’s Ultomiris approved for use on children in EU

September 3, 2021 Medical Communications, Research and Development

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …
News
andrei_r_-_shutterstock_1935537274_720

NICE and Cochrane to collaborate on living recommendations

September 1, 2021 Medical Communications, Research and Development

NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026